Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Meijer, Inc. et al v. Abbott Laboratories
Case Number:
4:07-cv-05985
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Berger Montague
- Garwin Gerstein
- Girard Sharp
- Joseph Saveri Law Firm
- Kaplan Fox
- Kirkland & Ellis
- Kozyak Tropin
- Lieff Cabraser
- Munger Tolles
- Odom & Des Roches
- Radice Law Firm
- Spiegel Liao
- Winston & Strawn
Companies
Sectors & Industries:
-
April 08, 2011
Abbott To Pay $52M To Norvir Direct Purchaser Class
Abbott Laboratories agreed in a California federal court on Friday to pay direct purchasers of its HIV drugs Norvir and Kaletra $52 million to resolve a consolidated antitrust class action.
-
August 19, 2008
Abbott's Appeal Tentatively OK'd In Norvir Suit
A district judge in California has tentatively given the green light for Abbott Laboratories to seek interlocutory appeal of several contentious antitrust issues that have arisen in one of several suits the company is facing for allegedly jacking up the price of its HIV medication Norvir.